Gala Pharmaceutical (Gala Pharmaceutical) Interest Coverage : 0 (At Loss) (As of May. 2019)

Gala Pharmaceutical Interest Coverage Chart

Gala Pharmaceutical Quarterly Data
	Aug14	Nov14	Feb15	May15	Aug15	Nov15	Feb16	May16	Aug16	Nov16	Feb17	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19
Interest Coverage	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Gala Pharmaceutical's Interest Coverage

For the Biotechnology subindustry, Gala Pharmaceutical's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gala Pharmaceutical's Interest Coverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gala Pharmaceutical's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Gala Pharmaceutical's Interest Coverage falls into.

Gala Pharmaceutical Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Else if Interest Expense is negative and Operating Income is negative, then

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Gala Pharmaceutical's Interest Coverage for the fiscal year that ended in Nov. 2018 is calculated as

Here, for the fiscal year that ended in Nov. 2018, Gala Pharmaceutical's Interest Expense was $-0.07 Mil. Its Operating Income was $-1.72 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

Gala Pharmaceutical's Interest Coverage for the quarter that ended in May. 2019 is calculated as

Here, for the three months ended in May. 2019, Gala Pharmaceutical's Interest Expense was $-0.06 Mil. Its Operating Income was $-0.48 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Gala Pharmaceutical  (OTCPK:GLPH) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Gala Pharmaceutical Interest Coverage Related Terms

Thank you for viewing the detailed overview of Gala Pharmaceutical's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Gala Pharmaceutical (Gala Pharmaceutical) Business Description